Compared side by side

PT-141 vs Melanotan II: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

PT-141 (bremelanotide) is a close analog of Melanotan II, developed for sexual function after Melanotan II caused erections in trials. Melanotan II acts on four melanocortin receptors and is run mainly for a tan, with libido and appetite effects alongside; PT-141 acts mainly on MC4R and MC1R and is taken as needed, 1–2 hours before. PT-141 is FDA-approved as Vyleesi for low sexual desire in premenopausal women, and frequent use of either darkens the skin.

Side by side

ComparedPT-141Melanotan II
CategorySexual healthSexual health
Also known asBremelanotide, PT141, VyleesiMT-2, MT2, Melanotan 2
What it isAn FDA-approved, as-needed treatment for low sexual desire in premenopausal women that acts through brain melanocortin receptors rather than blood flow (flibanserin/Addyi is the other, daily option).A broad-spectrum melanocortin agonist originally developed for sunless tanning.
How it worksMelanocortin receptor agonist (mainly MC4R and MC1R at the approved dose) that acts in the brain to increase sexual desire and arousal; the label says the exact mechanism is unknown. Doesn't work by increasing genital blood flow like PDE5 inhibitors (Viagra etc.), though it can briefly raise blood pressure. FDA-approved as Vyleesi (2019) for acquired, generalized HSDD in premenopausal women.Melanocortin receptor agonist (MC1R, MC3R, MC4R, MC5R). Stimulates melanogenesis (skin tanning), increases libido via CNS pathways, and can reduce appetite (a side effect in one small trial; the MC4R appetite mechanism comes from rodent work). Structurally similar to alpha-MSH.
Commonly reportedA noticeable rise in desire and arousal an hour or so after dosing (men often describe firmer or spontaneous erections), nausea that is often worst with the first dose, facial flushing, and headache on dosing days. Frequent use can cause skin darkening.Nausea and facial flushing after the first doses, easing with continued use; a fast, deep tan with freckles and moles visibly darkening; and spontaneous erections, frequent yawning and reduced appetite. Monitor moles carefully — it darkens all pigmented skin, and FDA cites melanoma reports.
Studied rangeResearch range: 0.5–2 mg, starting dose 1.25 mg. Studied in research — not a recommendation. FDA-approved as Vyleesi: 1.75 mg SubQ as needed, at least 45 minutes before sex (at most once a day, 8 times a month), for premenopausal women with acquired, generalized low sexual desire (HSDD).Research range: 250–500 mcg. Studied in research — not a recommendation.
How oftenAs needed, 1–2 hours beforeLoading: 250mcg daily for 1-2 weeks. Maintenance: 250-500mcg 2-3x/week or as needed.
Half-life~2.7 hours (FDA label; range 1.9–4.0 hours)Unknown in humans
RouteSubQ injectionSubQ injection
Typical runAs-needed use. Daily use leads to hyperpigmentation — limit frequency.Loading phase until desired tan achieved, then reduce to maintenance. Sun or UV exposure enhances tanning effect.
EvidenceEstablished: clinical trials or FDA-approved use existsEmerging: primarily preclinical / limited human data
Common side effectsNausea (most common), flushing, blood pressure elevation, spontaneous erections, hyperpigmentation with frequent useNausea, facial flushing, spontaneous erections, fatigue, darkening of moles/freckles, yawning

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking PT-141 or Melanotan II? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

PT-141

  • Day 1–1 First dose — give it 45 minutes
  • Day 1–7 Nausea fades with experience
  • Day 1–1 Timing and dose are the two dials that matter

Every card for PT-141, with its sources

Melanotan II

  • Day 1–3 Start low — your body needs to adjust
  • Day 3–7 Melanocytes are waking up
  • Day 7–14 The tan is developing
  • Day 14–28 Transition to maintenance

Every card for Melanotan II, with its sources

Together or one or the other

PT-141 and Melanotan II are a common stack: Melanotan II lists PT-141 among its common stacks.

Community · PT-141

PT-141 + MT-2: targeted vs broad

PT-141 is a close analog of Melanotan II (it differs only at the tail end of the molecule), developed for sexual function after MT-II caused erections; it didn't drop the tanning receptor. Stacking both is redundant for libido — they hit the same receptors. Some use MT-2 for tanning and PT-141 for targeted as-needed arousal.

Community · Melanotan II

MT-2 is PT-141's parent compound

PT-141 is a close analog of MT-2 that was developed specifically for sexual function. If you're already on MT-2, the libido boost is built in — adding PT-141 on top is redundant for that effect. MT-2 is the broader tool; PT-141 is the as-needed one.

Questions people ask

How long do PT-141 and Melanotan II last?

The half-life of PT-141 is ~2.7 hours (FDA label; range 1.9–4.0 hours). The half-life of Melanotan II is unknown in humans.

How often are PT-141 and Melanotan II taken?

PT-141: as needed, 1–2 hours before. Route: SubQ injection. Melanotan II: loading: 250mcg daily for 1-2 weeks. Maintenance: 250-500mcg 2-3x/week or as needed. Route: SubQ injection.

How are PT-141 and Melanotan II dosed in research?

The research range for PT-141 is 0.5–2 mg, with a 1.25 mg starting dose. Studied in research — not a recommendation. FDA-approved as Vyleesi: 1.75 mg SubQ as needed, at least 45 minutes before sex (at most once a day, 8 times a month), for premenopausal women with acquired, generalized low sexual desire (HSDD). The research range for Melanotan II is 250–500 mcg. Studied in research — not a recommendation.

What are the common side effects of PT-141 and Melanotan II?

For PT-141, the library lists: nausea (most common), flushing, blood pressure elevation, spontaneous erections, hyperpigmentation with frequent use. For Melanotan II: nausea, facial flushing, spontaneous erections, fatigue, darkening of moles/freckles, yawning.

Are PT-141 and Melanotan II taken together?

PT-141 and Melanotan II are a common stack: Melanotan II lists PT-141 among its common stacks. PT-141 is a close analog of Melanotan II (it differs only at the tail end of the molecule), developed for sexual function after MT-II caused erections; it didn't drop the tanning receptor. Stacking both is redundant for libido — they hit the same receptors. Some use MT-2 for tanning and PT-141 for targeted as-needed arousal.

Each one in full

Track it in the app

PepVault for iPhone

Taking PT-141 or Melanotan II? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo